Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and GI oncology diseases, ...
A heart attack is far from an isolated, acute event. The consequences of an attack can cause serious and lasting damage, ...
No-reflow syndrome can affect people after a heart attack or a medical procedure. Dr Ashok Seth explains why clear arteries ...
Many promising therapies fail because preclinical models do not fully capture the complexity of the human heart. A new review ...
The human heart must constantly adapt to changing demands—a task that requires tightly coordinated molecular shuffling in ...
Researchers at the University Medical Center Göttingen (UMG) and the University Hospital of Schleswig-Holstein (UKSH) have ...
Researchers have developed a scalable bioreactor-based system to produce cardiac organoids that successfully integrated into ...
Accurately measuring electrical signals and calcium levels in the heart can lead to earlier treatment of potentially fatal conditions, such as heart attack or congestive heart failure. Calcium plays ...
A new type of tissue-engineered cardiac patch could not only seal defective areas of the heart, as has been the case up to now, but also heal them. An interdisciplinary team led by ETH Zurich has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results